Merck KGaA's stock remains a 'hold' due to its high valuation, trading at an earnings multiple of around 20 and a 4.5% free ...
DTE), DT Midstream Inc (Symbol: DTM), and Merck & Co Inc (Symbol: MRK) will all trade ex-dividend for their respective upcoming dividends. DTE Energy Co will pay its quarterly dividend of $1.09 on ...
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The company offers human health pharmaceutical for various areas ...
Investing.com – U.S. stocks were mixed after the close on Friday, as gains in the Financials, Utilities and Consumer Goods sectors... Investing.com -- U.S. stocks rallied from a considerable ...
Investing.com – U.S. stocks closed higher on Friday, as investors shrugged off U.S. political turmoil and piled back into... Investing.com – U.S. stocks were higher after the close on Friday ...
Investors in Merck & Co Inc (Symbol: MRK) saw new options begin trading today, for the April 11th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MRK ...
The data to be presented encompasses five of the company’s novel drug candidates: BCR-ABL tyrosine kinase inhibitor olverembatinib (HQP1351), Bcl-2 inhibitor lisaftoclax (APG-2575), FAK/ALK/ROS1 ...
Quibim, a global company pioneering imaging biomarkers for precision medicine, announces that its prostate cancer lesion detection capability of its flagship QP-Prostate® CAD solution has received 510 ...
Fortive Corporation ("Fortive") today announced that James A. Lico, President and Chief Executive Officer, and Olumide Soroye, President and Chief Executive Officer of Intelligent Operating Solutions ...
The general mood among these heavyweight investors is divided, with 63% leaning bullish and 36% bearish. Among these notable ...
Merck & Co. has agreed to license an investigational oral small molecule lipoprotein(a) inhibitor from Jiangsu Hengrui Pharmaceuticals in a deal potentially worth more than $2 billion to the ...
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results